Effects of Non-Invasive Brain Stimulation on Soldiers' Cognitive and Functional Performance
1 other identifier
interventional
28
1 country
1
Brief Summary
Non-invasive brain stimulation has been shown to alter performance in both clinical and healthy populations on cognitive tasks. While the performance alterations have generally been shown to result in enhancement, mixed results remain in the literature. Much of the mixed results within the literature have been attributed to the use of different stimulation parameters, targeting of different brain areas, and using a variety of performance measures or assessing different constructs. However, non-invasive brain stimulation is a desirable method for enhancing Soldier performance given the ease of administration and minimal side effects as compared to other forms of performance enhancement (e.g., pharmaceuticals, caffeine). The objective of the current study is to evaluate the effects of non-invasive brain stimulation to the left dorsolateral prefrontal cortex in enhancing Soldier cognitive skills and performance on military tasks. A double blind within-subjects design will be used with healthy, rested Soldiers who will receive non-invasive brain stimulation and perform basic cognitive and operationally relevant tasks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2019
CompletedFirst Posted
Study publicly available on registry
November 7, 2019
CompletedStudy Start
First participant enrolled
December 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedJanuary 25, 2022
January 1, 2022
1.5 years
November 5, 2019
January 24, 2022
Conditions
Outcome Measures
Primary Outcomes (7)
Military task performance
Patrol exertion multitask
Folllowing stimulation; task lasts approximately 20 min
Military task performance
Target acquisition
Folllowing stimulation; task lasts approximately 40 min
Cognitive function - Selective Attention
Stroop test
Approximately 3 minutes during stimulation
Cognitive function - Multitasking/Working Memory
Dual n-back
Approximately 5 minutes during stimulation
Cognitive function - Working Memory
Digit span task
Approximately 2 minutes during stimulation
Cognitive function - Sustained attention
Rapid Visual Information Processing Task
Approximately 7 minutes during stimulation
Cognitive function - Executive function
Shifting Attention Task: Digit symbol substitution task
Approximately 2 minutes during stimulation
Secondary Outcomes (3)
Cognitive function - Impulsivity/Motor Control
Approximately 3 minutes after stimulation
Cognitive function - Risk Taking/ Decision Making
Approximately 1 minute after stimulation
Cognitive function - Cognitive Flexibility
Approximately 5 minutes after stimulation
Other Outcomes (7)
Confounding factor - Sleepiness
Approximately 1 minute, before and after stimulation
Confounding factor - Circadian typology
Approximately 15 minutes during intake
Moderator variable - Intelligence
Approximately 15 minutes during intake
- +4 more other outcomes
Study Arms (3)
Active anodal stimulation
EXPERIMENTALactive anodal stimulation at F3, cathode placed on contralateral bicep
Active cathodal stimulation
EXPERIMENTALactive cathodal stimulation at F3, anode placed on contralateral bicep
Sham stimulation
SHAM COMPARATORsham stimulation that will be counterbalanced between subjects such that half will receive sham stimulation configured as condition 1 (anode F3, cathode bicep) and half will receive condition 2 (cathode F3, anode bicep)
Interventions
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that stimulates the brain through the application of a low-intensity electrical current, typically ranging from 1 to 2 milliamps (mA), via electrodes placed on an individual's scalp. During the active stimulation sessions, 2 mA of stimulation will be applied for 30 minutes. During the sham stimulation session, 2 mA of stimulation will be applied over the course of 90 sec, the electrodes will remain in place for the 30 minute duration.
Eligibility Criteria
You may qualify if:
- Must be 18 (if active duty), 19 (if non-active duty) up to 40 years old.
- Must have normal hearing, vision or corrected to normal vision, and cognitive function as determined by self-report and screening by study physician
- Must have obtained at minimum 6 hours of sleep prior to data collection, as assessed by actigraphy data and self-report.
- Must have refrained from consumption of caffeine, 16 hours, nicotine, 2 hours, and alcohol, 24 hours, prior to the study, assessed by self-report.
You may not qualify if:
- Haven taken any medications which induce drowsiness, such as over-the-counter antihistamines within 24 hours of participation in the study. Any self-medication will be assessed through self-report
- No current medical conditions or medications affecting cognitive function or attention.
- Any history of any attention deficit condition requiring medication.
- Any history of psychological/psychiatric disorder.
- Any history of seizures, migraines, or neurological disorders.
- History of a head injury involving loss of consciousness.
- Any metal implanted within the head (e.g., shrapnel, surgical clips) or any implanted devices (e.g., cardiac pacemaker, brain stimulator, hydrocephalic shunt).
- Skin condition on the scalp, such as psoriasis or eczema, or wounds on the head.
- Currently receiving hormonal therapy treatments, other than birth control or as determined by physicians.
- Potential for caffeine withdrawal symptoms that will impede cognitive testing.
- Females with a known pregnancy, who test positively for pregnancy, or refuse the test will be excluded, given the lack of available research regarding the effects of tDCS during pregnancy. Known pregnancy will be assessed during screening, females without a known pregnancy will be requested to provide a urine sample during the screening procedures to ensure the absence of pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U.S. Army Aeromedical Research Laboratory
Fort Rucker, Alabama, 36362, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katie Feltman, PhD
US Army Aeromedical Research Laboratory
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Subjects and the research team will both be blind to the stimulation condition delivered at each test session. Access will be limited to the study physicians, investigators, and device programmers.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2019
First Posted
November 7, 2019
Study Start
December 12, 2019
Primary Completion
June 1, 2021
Study Completion
September 30, 2021
Last Updated
January 25, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share